targeted cancer therapy: initial high concentration may slow down selection for resistance | aging
Published 1 month ago • 56 plays • Length 0:51Download video MP4
Download video MP3
Similar videos
-
1:00:00
aging and cancer
-
0:37
targeted therapy | cancer treatment | molecular approach | we cure fear first
-
0:52
the dominant cancer risk factor: age
-
2:43
targeted therapy for early-stage lung cancer
-
0:50
cancer therapy: essential applications of antibody-drug conjugates #cancerresearch #biotech
-
49:11
aging and cancer: nci director dr. norman sharpless at albert einstein college of medicine
-
59:39
measurements of aging to use in cancer cohort studies
-
43:02
morning medical update encore: inside operating room milestone for life-saving cancer treatment
-
33:55
thinking differently about cancer treatment regimens
-
58:02
treatment options for prostate cancer
-
2:14
first-line treatment decision making for elderly patients with nsclc
-
42:00
prospects for targeted therapy in ovarian cancer - by michael birrer, md, phd
-
49:47
understanding the treatment continuum with dr. jay jhaveri - zero prostate cancer summit 2022
-
1:36:21
perlmutter cancer center experts share latest updates in breast cancer research & treatment
-
51:36
dr. ron rosedale - 'the critical connection between protein, cancer, aging and tor'
-
52:57
personalised treatment of breast cancer: is there a realistic hope?
-
2:01:58
traco 2015: breast cancer - clinical trials
-
47:59
advances and challenges in targeting kinases in cancer therapeutics